Literature DB >> 35948810

Tumor necrosis factor alpha (TNF-α) blockage reduces acute inflammation and delayed wound healing in oral ulcer of rats.

Milena Oliveira Freitas1,2, Alline Pereira Rodrigues Fonseca1, Maria Thaynara de Aguiar1, Camila Costa Dias1, Rafael Linard Avelar2, Fabrício Bitu Sousa1,2, Ana Paula Negreiros Nunes Alves2, Paulo Goberlânio de Barros Silva3,4.   

Abstract

Oral traumatic ulcers (OTU) are common in dental routine, and the control of proinflammatory cytokines, such as the tumor necrosis factor-alpha (TNF-α), may interfere with OTU repair. Our aim was to evaluate the role of TNF-α in the healing process of OTU in rats. Wistar male rats were divided into six groups: a control-group (treated with 0.1 mL/kg of saline) and five groups treated with anti-TNF-α infliximab (INF) at 1, 3, 5, 7, and 10 mg/kg immediately before OTU production. The animals were weighed (day 0) and euthanized on days 1, 3, 7, 14 and 21 after ulceration. The ulcers were clinically measured, and the mucosa samples were histologically (scores 0-4), histochemically (collagen assay (pircrosirius)), histomorphometrically (cell counting), and immunohistochemically (TNF-α, α-smooth-muscle-actin (α-SMA), monocyte-chemoattractive-protein-1 (MCP-1), interleukin-8 (IL-8), and fibroblast-growth-factor (FGF)) analyzed. The Evans blue assay was used to measure the vascular permeability. ANOVA-1-2-way/Bonferroni, Kruskal-Wallis/Dunn, and correlation analyses were performed (GraphPad Prism 5.0, p < 0.05). High doses of INF reduced the OTU area (p = 0.043), body mass loss (p = 0.023), vascular permeability (p < 0.001), and reduced delayed histologic scores (p < 0.05), polymorphonuclear (p < 0.001) and mononuclear (p < 0.001) cells, blood vessel counting (p = 0.006), and total (p < 0.001), type-I (p = 0.018), and type-III (p < 0.001) collagen. INF treatment reduced TNF-α immunostaining and delayed MPC-1, FGF, and α-SMA expression, with little/none influence in IL-8 immunostaining. TNF-α blockage by INF reduced acute inflammation in OTU but delayed cell migration and wound healing.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Inflammation; Infliximab; Oral ulcer; Tumor necrosis factor tumoral-alpha; Wound healing

Year:  2022        PMID: 35948810     DOI: 10.1007/s10787-022-01046-3

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   5.093


  30 in total

1.  Delayed healing of oral mucosa in a diabetic rat model: Implication of TNF-α, IL-1β and FGF-2.

Authors:  Luiz André C Brizeno; Ana Maria S Assreuy; Ana Paula N N Alves; Fabrício B Sousa; Paulo Goberlânio de B Silva; Suzana Cantanhede O Machado de Sousa; Nelise A S Lascane; Janaína Serra-Azul M Evangelista; Mário Rogério L Mota
Journal:  Life Sci       Date:  2016-05-14       Impact factor: 5.037

2.  The traditional Japanese medicine hangeshashinto alleviates oral ulcer-induced pain in a rat model.

Authors:  Suzuro Hitomi; Kentaro Ono; Kiichiro Yamaguchi; Kiyoshi Terawaki; Ryota Imai; Kunitsugu Kubota; Yuji Omiya; Tomohisa Hattori; Yoshio Kase; Kiyotoshi Inenaga
Journal:  Arch Oral Biol       Date:  2016-02-03       Impact factor: 2.633

3.  Effect of laser (λ 660 nm) and LED (λ 630 nm) photobiomodulation on formocresol-induced oral ulcers: a clinical and histological study on rodents.

Authors:  Fabiola Bastos de Carvalho; Aline Silva Andrade; Luis Cardoso Rasquin; Isabele Vieira de Castro; Maria Cristina Teixeira Cangussu; Antônio Luiz Barbosa Pinheiro; Jean Nunes dos Santos
Journal:  Lasers Med Sci       Date:  2014-10-30       Impact factor: 3.161

Review 4.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Authors:  Tim Bongartz; Alex J Sutton; Michael J Sweeting; Iain Buchan; Eric L Matteson; Victor Montori
Journal:  JAMA       Date:  2006-05-17       Impact factor: 56.272

5.  Refractory Oral Ulcer Responsive to Infliximab: A Case Report.

Authors:  Keiko Ito; Kentaro Shikata; Kouichi Haba; Takaaki Ito
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2019-06-28       Impact factor: 1.538

6.  Modulation of collagen synthesis by growth factors: the role of ascorbate-stimulated lipid peroxidation.

Authors:  J C Geesin; L J Hendricks; J S Gordon; R A Berg
Journal:  Arch Biochem Biophys       Date:  1991-08-15       Impact factor: 4.013

Review 7.  Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.

Authors:  G Almoznino; E Ben-Chetrit
Journal:  Clin Exp Rheumatol       Date:  2007 Jul-Aug       Impact factor: 4.473

8.  Evidence for the involvement of TNF-α and IL-1β in the antinociceptive and anti-inflammatory activity of Stachys lavandulifolia Vahl. (Lamiaceae) essential oil and (-)-α-bisabolol, its main compound, in mice.

Authors:  Rosana S S Barreto; Jullyana S S Quintans; Ruthy K L Amarante; Tainá S Nascimento; Rosana S Amarante; André S Barreto; Erik W M Pereira; Marcelo C Duarte; Henrique D M Coutinho; Irwin R A Menezes; Gokhan Zengin; Abdurrahman Aktumsek; Lucindo J Quintans-Júnior
Journal:  J Ethnopharmacol       Date:  2016-06-09       Impact factor: 4.360

9.  Successful treatment of oral Crohn's disease by anti-TNF-alpha dose escalation - a case report.

Authors:  Arne Bokemeyer; Nicolas Tentrop; Peter J Barth; Frank Lenze; Karin Hengst; Johannes Kleinheinz; Dominik Bettenworth
Journal:  BMC Gastroenterol       Date:  2018-06-18       Impact factor: 3.067

10.  Wound Healing in Streptozotocin-Induced Diabetic Rats Using Atmospheric-Pressure Argon Plasma Jet.

Authors:  Kuang-Yao Cheng; Zhi-Hua Lin; Yu-Pin Cheng; Hsien-Yi Chiu; Nai-Lun Yeh; Tung-Kung Wu; Jong-Shinn Wu
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.